Korea do not accept extension of patent period by 5 years

Published: 2006-10-31 07:00:00

Updated: 2006-10-31 07:00:00

The Ministry of Health and Welfare said The Korean government has not promised to accept the U.S. government's requests regarding an extension of the patent period by five years for their drugs to increase their prices in the fourth round of the free trade agreement (FTA) talks, while denying the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK